Clinical Trial

Morphometric Markers of the Effectiveness of Micropulse Cyclophotocoagulation

Study acronym: MMEMC
Recruiting
View on ClinicalTrials.gov →
Summary
This prospective study aims to evaluate morphometric markers of treatment response following micropulse transscleral cyclophotocoagulation (MP-CPC) in patients with glaucoma. The study will assess changes in choroidal thickness and the choroidal vascularity index (CVI) measured by optical coherence tomography (OCT) before treatment, 3-7 days after the procedure, and 1 month postoperatively. Intraocular pressure (IOP) will be measured at the same time points. The correlation between changes in choroidal thickness, the choroidal vascularity index (CVI) and IOP reduction will be analyzed. Additionally, the study seeks to determine the minimal baseline choroidal thickness associated with a clinically significant hypotensive effect after MP-CPC.
Trial Details
NCT Number NCT07592923
Lead Sponsor Kazakh Eye Research Institute
Conditions Glaucoma
Enrollment 20 participants
Start Date 2026-05-18
Primary Completion 2026-08-18 (estimated)
Study Completion 2026-08-18 (estimated)
Updated on ClinicalTrials.gov 2026-05-18